Acute mountain sickness (AMS): Acute mountain sickness (AMS) is the effect on the body of being in a high altitude environment. AMS is common at high altitudes, that is above 8,000 feet (2,440 meters). Three-quarters of people have mild symptoms of AMS over 10,000 feet (3,048 meters). The occurrence of AMS depends on the altitude, the rate of ascent, and individual susceptibility.
Mild AMS: Many people experience mild AMS during the acclimatization process (the first 1 to 3 days at a given altitude). Symptoms usually start 12-24 hours after arrival at altitude and include headache, dizziness, fatigue, shortness of breath, loss of appetite, nausea, disturbed sleep, and a general feeling of malaise. These symptoms tend to be worse at night when respiratory drive is decreased.
Mild AMS does not usually interfere with normal activity and symptoms generally subside within 2-4 days as the body acclimatizes. As long as symptoms are mild, and only a nuisance, ascent can continue at a moderate rate. When hiking, it is essential to communicate any symptoms of illness immediately to others on your trip. AMS is considered to be a neurological problem caused by changes in the central nervous system. It is basically a mild form of high altitude cerebral edema.
Mild AMS is usually treated with pain medications for headache and a drug called DIAMOX which allows one to breathe faster and so metabolize more oxygen, thereby minimizing the symptoms caused by poor oxygenation. This is especially helpful at night when respiratory drive is decreased. Since it takes a while for DIAMOX to have an effect, it is advisable to start taking it 24 hours before going to altitude and continue it for at least 5 days at higher altitude.
Moderate AMS: Moderate AMS includes severe headache (not relieved by medication), nausea, vomiting, increasing weakness and fatigue, shortness of breath, and decreased coordination. Normal activity is difficult. At this stage, only advanced medications or descent can reverse the problem. Descending even a few hundred feet (70-100 meters) may help. Definite improvement is usually seen in descents of 1,000-2,000 feet (305-610 meters). Twenty-four hours at the lower altitude usually results in significant improvement. The person should remain at lower altitude until symptoms have subsided (up to 3 days). At that point, the person has become acclimatized to that altitude and can begin ascending again.
The best test for moderate AMS is to have the person “walk a straight line” heel to toe. Just like a sobriety test, a person with AMS will be unable to walk a straight line. This is a clear indication that immediate descent is required. It is important to get the person to descend before the AMS reaches the point where they cannot walk on their own.
Severe AMS: Severe AMS presents as an increase in the severity of the symptoms, including greater shortness of breath at rest, inability to walk, decreasing mental status, and fluid buildup in the lungs. Severe AMS requires immediate descent to lower altitudes: 2,000 – 4,000 feet (610-1,220 meters).
The only cure for AMS is acclimatization or descent. (Based in part on the Princeton University Outdoor Action “Guide to High Altitude: Acclimatization and Illnesses” by Rick Curtis).
- Acute myelogenous leukemia
Acute myelogenous leukemia: Abbreviated AML. Also called acute myeloid leukemia or acute nonlymphocytic leukemia (ANLL). A quickly progressive malignant disease in which there are too many immature blood-forming cells in the blood and bone marrow, the cells being specifically those destined to give rise to the granulocytes or monocytes, both types of white blood cells […]
- Acute myeloid leukemia
Acute myeloid leukemia: A quickly progressive malignant disease in which there are too many immature blood-forming cells in the blood and bone marrow, the cells being specifically those destined to give rise to the granulocytes or monocytes, both types of white blood cells that fight infections. In AML, these blasts do not mature and so […]
- Acute myocardial infarction
Acute myocardial infarction: A heart attack. The term “myocardial infarction” focuses on the heart muscle, which is called the myocardium,and the changes that occur in it due to the sudden deprivation of circulating blood. This is usually caused by arteriosclerosis with narrowing of the coronary arteries, the culminating event being a thrombosis (clot). The main […]
- Acute necrotizing ulcerative gingivitis (ANUG)
Acute necrotizing ulcerative gingivitis (ANUG): This is trench mouth, a progressive painful infection with ulceration, swelling and sloughing off of dead tissue from the mouth and throat due to the spread of infection from the gums. Certain germs (including fusiform bacteria and spirochetes) have been thought to be involved, but the full story behind this […]
- Acute nonlymphocytic leukemia
Acute nonlymphocytic leukemia: Abbreviated ANLL. More commonly called acute myeloid leukemia (AML). A quickly progressive malignant disease in which there are too many immature blood-forming cells in the blood and bone marrow, the cells being specifically those destined to give rise to the granulocytes or monocytes, both types of white blood cells that fight infections. […]